Data / Form D filings / Phosplatin Therapeutics Inc.
Phosplatin Therapeutics Inc.: Form D filings
Phosplatin Therapeutics Inc., a pharmaceuticals company in New York, NY, filed 3 Form D notices with the SEC between 2018 and 2021. The latest, on December 15, 2021, reports $37.3 million sold of a $37.3 million offering to 41 investors.
Find out what Phosplatin Therapeutics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1350 AVENUE OF THE AMERICAS, 23rd Floor, New York, NY, 10019
- Phone
- (646) 380-2441
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1757705
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 15, 2021 | New notice | $37,295,619 | $37,295,619 | $0 | 41 | Dec 3, 2021 | sec.gov |
| Aug 14, 2020 | New notice | $18,400,000 | $18,400,000 | $0 | 40 | Jul 31, 2020 | sec.gov |
| Nov 8, 2018 | New notice | $16,605,000 | $16,605,000 | $0 | 48 | Oct 31, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rosita Leong | Director | |
| Robert Fallon | Executive Officer, Director | |
| John Caouette | Director | |
| Peter Espig | Director | |
| Frances Bonham | Executive Officer | |
| Neil Sunderland | Director | |
| Charles Stuckey | Director | |
| Elizabeth Tallett | Director | |
| Matthew Price | Director |
Other pharmaceuticals companies in New York that filed recently
- NBO Pharma Inc. $238,000 · Nov 9, 2026
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Dec 13, 2021 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Phosplatin Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.